Skip navigation

Global Health at R4D

Global Health

R4D leverages extensive networks and expertise to improve health and achieve equity in health outcomes for all people around the world. Whether it's assessing policies that can support research and development on new drugs and vaccines, exploring innovations in healthcare and connecting innovators to each other or to investors, supporting the growing global movement for universal health coverage, or producing on-demand research and forecasting to help countries and global institutions plan their healthcare futures, R4D’s global health work unlocks new possibilities for global health actors worldwide.

Featured Global Health Impacts
R4D is working with policymakers, implementers, researchers, and development partners to identify better ways for low- and middle-income countries to improve access to effective health care and reduce poverty from catastrophic health care expenditures by moving towards universal health coverage (UHC).
Global Health Impact
Since 2010, the Center for Health Market Innovations (CHMI) has been documenting health market innovations across the developing world. CHMI envisions a world in which the private sector – where the majority of people in many countries go for health care – reaches its potential as a source for quality, accessible and affordable health care for all people.
R4D worked with health ministries around the world to build the talents of their leaders and strengthen their institutions. Through the Ministerial Leadership Initiative for Global Health (MLI), R4D helped health ministers and senior staff in Ethiopia, Mali, Nepal, Senegal, and Sierra Leone build effective leadership and strong capacity to develop and implement sound policies.
R4D modeled and analyzed the long term costs and financing options for AIDS over the next two decades in a study examining how major policy shifts now can improve the impact of future expenditures. Authors from the financing group of the aids2031project, including R4D Managing Director Robert Hecht, addressed critical questions, taking a long-term view of financial requirements under different possible scenarios as the HIV/AIDS pandemic unfolds over the next two decades up to 2031, the year that will mark the 50th anniversary of AIDS.